ID   LACC-1
AC   CVCL_9U23
SY   Lacrimal gland Adenoid Cystic Carcinoma-1
DR   Wikidata; Q54901891
RX   DOI=10.4103/2468-5585.200513;
RX   PubMed=25962898;
CC   Population: Chinese.
CC   Doubling time: ~37.1 hours (PubMed=25962898).
CC   Derived from site: In situ; Lacrimal gland; UBERON=UBERON_0001817.
DI   NCIt; C4540; Lacrimal gland adenoid cystic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
RX   DOI=10.4103/2468-5585.200513;
RA   Liu N.-N., Zhang S.-L., Chen W.;
RT   "The cross-contaminated cell lines of adenoid cystic carcinoma:
RT   a crucial concern.";
RL   Transl. Surg. 2:10-13(2017).
//
RX   PubMed=25962898; DOI=10.3892/or.2015.3925;
RA   Lin T.-T., Zhu L.-M., Zhou B.-Q., Xie L.-F., Lv J.-M., Dong L.-J.,
RA   He Y.-J.;
RT   "Establishment and characterization of a cell line from human adenoid
RT   cystic carcinoma of the lacrimal glands and a nude mouse
RT   transplantable model.";
RL   Oncol. Rep. 33:2797-2806(2015).
//